Smoking and lung cancer: scientific challenges and opportunities.
Wynder
E L
EL
Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595.
Hoffmann
D
D
D000230:Adenocarcinoma / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D001741:Black or African American; D044383:Black People; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008175:Lung Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000473:pathology; D008297:Male; D009602:Nitrosamines / Q000009:adverse effects*; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D014028:Tobacco Smoke Pollution / Q000009:adverse effects; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D044465:White People
D009602:Nitrosamines; D014028:Tobacco Smoke Pollution; C016583:4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone